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S-100 PROTEIN RELEASE IN A RANGE OF CARDIOTHORACIC SURGICAL PROCEDURES 
P. Kumar, MA, BM, BCh, a K. Dhital, BSc, FRCS, a M. Hossein-Nia, BSc, PhD, b S. Patel, b D. Holt, PhD, FRCPath, b 
and T. Treasure, MD, MS, FRCS, a London, United Kingdom 
In studies of perioperative brain injury physicians 
rely on clinically evident stroke to diagnose discrete 
damage and neuropsychologic tests for global chang- 
es.1, 2 Neurologic examination may miss diffuse injury 
and infarction in silent areas, and neuropsychologic 
testing is time-consuming and applicable only if a 
battery of tests can be performed before the operation 
and repeated several weeks later under identical cir- 
cumstances. 3 S-100 protein promises to be a very 
practical way of quantifying central nervous system 
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damage and might overcome both of these deficien- 
cies.4. 5 
S-100 protein is a calcium-binding dimer with alpha 
and beta subunits. The alpha-beta nd beta-beta forms 
of S-100 are found predominantly in neural tissue, have 
a half-life of about 2 hours, and are excreted by the 
kidney.4, s Increased levels of S-100 in the cerebrospinal 
fluid and serum have been reported after head injury 
and stroke. We report the results of a preliminary study 
of a series of patients grouped according the expected 
magnitude of cerebral hazard. 
Methods. Patients were placed into four groups strati- 
fied according to increasing risk for cerebral injury. Group 
1 comprised patients having a major operation, lung 
resection, without cardiopulmonary b pass (CPB). All the 
other patients had CPB with a membrane oxygenator and 
arterial line filter. Group II had a coronary artery opera- 
tion at 32 ° C with intermittent ventricular fibrillation and 
ischemia, group III had aortic root replacement with cold 
blood cardioplegia and a CPB temperature of 28 ° C, and 
group IV had aortic surgery with a similar CPB technique 
with, in addition, aperiod of deep hypothermic circulatory 
arrest at 18 ° C. 
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Fig. 1. Median S-100 levels for the four groups against ime. 0 = preoperative l vel; thereafter, times 
denote postoperative time. Thorac, Thoracotomy and lung resection; CABG, coronary artery bypass 
grafting; AR, aortic root replacement without circulatory arrest; Circ Arrest, aortic surgery with a period of 
hypothermic circulatory arrest. 
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Fig. 2. AUC S-100 for four groups. Thorac, Thoracotomy 
and lung resection; CABG, coronary artery bypass graft- 
ing; AR, aortic root replacement without circulatory ar- 
rest; Circ Arrest, aortic surgery with a period of hypother- 
mic circulatory arrest. 
In all patients we measured the serum S-100 level 
before the induction of anesthesia. In group I we 
took further samples at 1/2 hour, 1 hour, 2 hours, 4 hours, 
and 24 hours after extubation, and we took samples at 
the same time intervals after the end of CPB for the 
three cardiac surgical groups. We used immunoradio- 
metric assay to measure the serum S-100 level (Sangtec 
100, AB Sangtec Medical, Bromma, Sweden). The 
Sangtec 100 assay measures the neurospecific soforms 
of S-100 protein, and its level is less than 0.2 Fg/L in 
95% of the normal healthy population. 
Results. Nineteen patients were studied: four under- 
went lung resection, six had coronary operations, four 
had aortic root replacement without arrest, and five 
patients had circulatory arrest for aortic surgery. The 
mean ages were 66, 58, 56, and 64 years. The nadir 
temperatures were 37 ° C, 32 ° C, 28 ° C, and 18 ° C, re- 
spectively, and the CPB times averaged 100, 111, and 
109 minutes for the three cardiac groups. All the 
patients urvived the procedure, but there were three 
deaths in group IV. These three patients had undergone 
emergency operations for aortic dissection and died 1, 
3, and 10 days after the operation. 
The time course of S-100 protein release for the 
four groups is shown in Fig. 1. The area under the 
curve for S-100 (AUC S-100) protein release in every 
patient is shown in Fig. 2. In group IV, the circulatory 
arrest imes ranged from 9 to 32 minutes and the S-100 
AUC from 9.66 to 41.75 /xg/L.h. The Spearman rank 
correlation was 0.9 (p = 0.04). There were no clinically 
evident neurologic events among the survivors. 
Discussion. At baseline and in all patients not sup- 
ported by CPB, the S-100 level was below the limits 
of detection. The peak and AUC S-100 levels for 
groups II, III, and IV were proportional to the antici- 
pated hazard and followed a similar pattern. The 
highest level was usually at 30 minutes and the level 
was falling by an hour in 15 of 19 patients. By 24 hours 
after the operation the serum S-100 level had returned 
to normal. It is important o note that patients in 
different groups were operated on at different emper- 
atures with the nadirs being 37 ° C, 32 ° C, 28 ° C, and 
18 ° C, chosen in line with the intention of protecting 
the brain from injury. So far as we know, S-100 protein 
release is not a temperature-related phenomenon, and 
in our data there was no correlation. However, a 
larger cohort would be required to confirm this obser- 
vation. 
These results are from a preliminary study. We can 
make only cautious interpretations of the data, but 
they support the feasibility of using S-100 to mea- 
sure brain injury related to surgery. We are in the 
process of correlating S-100 protein release with 
changes in neuropsychologic tests to establish its clini- 
cal relevance. 
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